S Aronoff

1.7k citations
6 papers · 642 · 1 hit paper · h-index 6

Impact in

Papers in

S Aronoff

6 papers receiving 597 citations

S Aronoff's Hit Papers

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. 2000 · 521 citations
5210+8+17Years since publication100200300400500

Peers

S Aronoff
Comparison fields: 5 of 66
  • Endocrinology, Diabetes and Metabolism 295
  • Nephrology 31
  • Pharmacology 62
  • Molecular Biology 264
  • Physiology 86
Replace David Brady with:
David Brady United States
G Di Maro Italy
Russell Esterline United States
P Stolba Czechia
M. Miola Italy
Morris E. Berger United States
J. Rosenthal Germany
J Rosenthal Germany
Farshad Kajbaf France
Aldo Soro Italy
S Aronoff relative to David Brady United States David Brady's profile →
Citations per field
00.5×11×
David Brady · 1×
Citations per year

Countries citing papers authored by S Aronoff

Since Specialization
Citations

This map shows the geographic impact of S Aronoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Aronoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Aronoff more than expected).

Fields of papers citing papers by S Aronoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Aronoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Aronoff. The network helps show where S Aronoff may publish in the future.

Co-authors

The 25 scholars most cited alongside S Aronoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S Aronoff Line = papers co-authored together S Aronoff links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
Hit paper breakdown →
2000521
2 198246
3 200744
4 197313
5 197613
6
Use of a premixed insulin regimen (Novolin 70/30) to replace self-mixed insulin regimens.
19945

About S Aronoff

S Aronoff is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery, Nephrology and Pulmonary and Respiratory Medicine, having authored 6 papers that have together received 642 indexed citations. Recurring topics across this work include Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Ion Transport and Channel Regulation (2 papers), Diabetes Treatment and Management (2 papers), Diabetes Management and Research (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Electrolyte and hormonal disorders (1 paper), Pancreatic function and diabetes (1 paper) and Bipolar Disorder and Treatment (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (295 citations), Nephrology (31 citations), Pharmacology (62 citations), Molecular Biology (264 citations) and Physiology (86 citations). S Aronoff has collaborated with scholars based in United States, Netherlands and Israel. Frequent co-authors include Sidney Rosenblatt, J. Egan, Annette Mathisen, Susan S. Braithwaite, Roger H. Unger, M. Nagulesparan, I Klimeś, D. M. Mott, Peter H. Bennett and Richard D. Rohde. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Nephrology Dialysis Transplantation, Diabetes Care, American Journal of Physiology-Legacy Content and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact